Critical Contrast: Solventum (NYSE:SOLV) and ClearPoint Neuro (NASDAQ:CLPT)

ClearPoint Neuro (NASDAQ:CLPT) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Institutional & Insider Ownership

30.1% of ClearPoint Neuro shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares ClearPoint Neuro and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-59.64%	-62.10%	-38.39%
Solventum	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and price targets for ClearPoint Neuro and Solventum, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	0	0	3	0	3.00
Solventum	1	9	1	0	2.00

ClearPoint Neuro presently has a consensus price target of $19.67, suggesting a potential upside of 7.35%. Solventum has a consensus price target of $68.29, suggesting a potential downside of 7.77%. Given ClearPoint Neuro’s stronger consensus rating and higher probable upside, research analysts plainly believe ClearPoint Neuro is more favorable than Solventum.

Earnings and Valuation

This table compares ClearPoint Neuro and Solventum”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$23.95 million	21.10	-$22.09 million	($0.69)	-26.55
Solventum	N/A	N/A	N/A	N/A	N/A

Solventum has lower revenue, but higher earnings than ClearPoint Neuro.

Summary

ClearPoint Neuro beats Solventum on 6 of the 9 factors compared between the two stocks.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.